San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Debut Biotechnology is raising $22,644,405.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Joshua Britton played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Debut Biotechnology
Debut creates natural ingredients using advanced biomanufacturing tools.

To learn more about Debut Biotechnology, visit http://debutbiotech.com/

Contact:
Joshua Britton, Chief Executive Officer
619-432-5177
https://www.linkedin.com/in/joshua-britton-4294a080/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved